LAHo! will top most as products sell’s in the thousands with professional services and procedures in 36 centers and 27 countries..profits$$ ..

..INKREDIBLE 3D BIOPRINTER
..The Magellan® technology
..H.I.F.U High Intensity Focused Ultrasound $7,500.00
..32” Portable Clean Room $4,500.00
..Photoactivation Device $3,650.00
..MiniCell CO2 Incubator $3,900.00

https://www.adimarket.net
https://www.adimarket.net/product-category/in-office-processing-equipment/

Lans Holdings Enters into Binding LOI to Acquire Global Stem Cells Group

..GSCG operates in the global stem cell market which is forecasted by Transparency Market Research to reach $270 billion dollars by 2025 of which roughly 40% or $100 billion will be derived from outside of North America and growing..

https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/


Physicians, researchers and likeminded business team for massive gains$$.



LAHO$

LAHO! Adimarket featured products!

Variable-speed benchtop centrifuge with speeds ranging from 100 to 3,500 rpm Compatible with four interchangeable swing-out rotors and a variety of adapters (sold separately)

INTEGRATED STEM CELL WORKSTATION
Multi-functional Bio-work station with built-in centrifuge, shaking incubator, particle meter. Stem Cell isolation or Cell Handling is ideally conducted in a clean environment. General centrifuge, cooling centrifuge. It’s designed for multi-purpose such is isolating cell or blood. 12ea of standard tubes (50 ml) can be rotated at one time.

BiosafePRP 30cc (Box of 50kits)
$2,550.00
PRO PRP Kit allows up to 12.8 times more concentrated platelet count than whole blood.


Magellan PRP
The Magellan® technology provides an automated dual spin processing system that can deliver (PRP) Platelet Rich Plasma as well as (PPP) Platelet Poor Plasma.

Photoactivation Device
$3,650.00
This LED Cell Activator device uses LED lights at a specific wavelength and wattage to increase cellular viability, proliferation and osteogenic differentiation.
https://www.adimarket.net/
In-Office Processing Equipment

MiniCell CO2 Incubator
$3,900.00
This is the smallest and most economical incubator for applications requiring CO2 gas control. Its small footprint makes the incubator ideal for use inside of biological safety cabinets, isolating sensitive cultures or for any laboratory simply trying to conserve bench spac

8? Wide Portable Clean Room
$4,250.00
For applications that require a compact and clean positive-pressure environment, the 18” Wide Mini Portable Clean Room Hood may be an excellent choice. This system is rated as an ISO Class 5 clean room cabinet
https://www.adimarket.net/product-category/in-office-processing-equipment/

Cellgenic Amniotic Fluid-Human placental Derived
$785.00 – $2,382.00
CELLGENIC AF is a connective tissue allograft flowable matrix. It's derived from chorion-free human placental tissue and amniotic fluid, cryopreserved to maintain the viability of the intercellular messengers. CELLGENICTM retains the biologic functionality that ensures symmetrical structure development, growth, and repair of the soft tissue by acting as a biologic matrix for use in filling defects, or for points of localized inflammation.

H.I.F.U High Intensity Focused Ultrasound
$7,500.00
The Vaginal Tightening HIFU System uses an noninvasive ultrasonic focusing technique to directly focus on the mucosal lamia and muscle layer.

Shockwave Machine
$3,500.00
A shockwave is defined as a wave with a rapid increase of pressure within a very short time and then having a gradual decrease of pressure with a small negative pressure phase

BEAR C2202 Centrifuge
$3,000.00
Low-speed laboratory bench-top centrifuge with universal swing-out rotor CRS 490. Up to 32 tubes. Max speed 3500 rpm. Max RCF 2300 G. Max volume of the liquid - 360 ml. Universal bucket-rotor CRS 490 allows to spin different types of tubes at the same time CE-certified.

INKREDIBLE 3D BIOPRINTER
The INKREDIBLE 3D Bioprinter is the next generation bioprinter, bringing scientists yet closer and faster to a desired future of medicine. It is the most user friendly bioprinter on the market and a complete standalone product for life science companies, researchers and innovators around the world.

32” Portable Clean Room
$4,500.00
Portable laminar flow hoods are small clean benches with light-weight, compact and space-saving design available in 24” and 32” width and three different materials: Clear static dissipative PVC, clear Non-dissipative PVC and white polypropylene.
https://www.adimarket.net/product-category/cellular-and-tissue-based-products/

Company is worth $Multi-MILLIONS $.0007 deal of a lifetime.


LAHO$

LAHO! GSCG Adimarket to Represent Magellan..



http://www.stemcellsgroup.com/magellan-autologous-platelet-separator/screen-shot-2017-11-28-at-2-42-03-am/
Global Stem Cells Group and its subsidiary Adimarket named representatives for Magellan Autologous Platelet Separator in Latin America and Middle East.

Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, and its subsidiary Adimarket have been named to represent the Magellan Autologous Platelet Separator in Latin America and Middle East.

Developed by Arteriorcyte Medical Systems, a leading medical device company headquartered in Hopkinton, Mass., the Magellan Autologous Platelet Separator is a high-tech, automated dual spin processing system designed for use in clinical laboratories or intraoperatively at the point-of-care for safe and rapid preparation of high-quality, platelet-rich plasma (PRP) as well as platelet poor plasma (PPP).

Global Stem Cells Group CEO Benito Novas says the Magellan system is a perfect fit for GSCG and Adimarket’s ever-growing list of high-tech regenerative medicine products and equipment, made available to physicians and qualified practitioners through the Adimarket online store.

“We share Arteriocyte’s commitment to research and development of blood component technology to advance treatments that benefit patients in the field of regenerative medicine,” Novas says. “The Magellan system furthers GSCG’s drive to invest in platelet separation technologies that focus on the development of new surgical applications for PRP and elevates these technologies to the next level.”

The fully-automated Magellan system is specifically designed to fractionate blood at bedside without a need for manual manipulation. At the end of its cycle, the Magellan PRP is delivered into a collection syringe, ready for immediate application.

As an industry leader, Adimarket added the Magellan Autologous Platelet Separator System to its online regenerative medicine store to allow physicians to meet the specific needs of each patient with fully customizable product volumes and platelet concentrations. The system can be programmed to deliver a volume of 3 – 10 mL from each processing cycle, allowing practitioners to customize the concentration per mL within the PRP. The Magellan system is approved for three processing cycles per disposable separation chamber, allowing for a maximum of 30 mL of product.

For more information, visit the Adimarket regenerative medicine online store website, email info@stemcellsgroup.com, or call 305-560-5337.

About Global Stem Cells Group
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/


https://www.stemcellsgroup.com/category/press-releases/page/7/

LAHO! GSCG Partner Magellan..

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149415546

cell therapy market [will] grow..around 36% by 2021,” read the report.

“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive

Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31 Million
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30

https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/

Global Stem Cells Group Announces Opening of Two New Stem Cell Centers

..This brings the total number of global Stem Cell centers to 36 worldwide in 27 countries.
..The new clinic in Valencia will be the group's third operation in Spain and the fourth in Europe.

https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503

Cellgenic..regenerative medicine and cellular therapies since 2005..


UNITED STATES STEM CELL THERAPY
More than a Decade of Stem Cell Therapy Experience

Safety along with the highest standards of medical ethics define the Cellgenics system.
We do not take stem cell treatments lightly. Our medical team adheres strictly to our inclusion and exclusion criteria. This leads to a higher efficacy rate because we are aware that not all conditions can be treated successfully with fresh autologous stem cells.

Our therapeutic protocols are designed and tailored for each patient, this means we have different systems in place for the isolation and delivery of the stem cells.
The Cellgenic sytem differs from other stem cell therapy facilities because:

Proprietary protocols have been developed by our faculty and implemented by hundreds of physicians around the world
There is a high rate of therapy success
An ethics committee has approved ongoing clinical trials

..Patients Treatment
+2000

Improvement and satisfaction
95%

Medical cases done
5000

http://cellgenic.com/our-story/#
http://cellgenic.com/articles/

LAHO! Amazing GSCG Advisory Board Members.

http://www.stemcellsgroup.com/advisory-board/

..Benito Novas, Global Stem Cells Group CEO Announces Opening of New Stem Cell Center in Valencia, Spain

http://www.stemcellsgroup.com/press-releases/

CHK! ..international petroleum products, which are down by 14% in the last month, driven by falling oil prices.

https://businesstech.co.za/news/energy/323385/big-petrol-price-cut-on-the-cards-for-july-but-theres-a-catch/

$1.50?

GBTC! 11k July BTC?

LAHO! GSCG Advisory Board Members awards recognition..at a glance.

..Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.

..Dr. Anoop Chaturvedi is the CEO of World Antiaging Network, the First International peer to peer platform of Antiaging physicians, the Founder President of Antiaging Medicine and Research

..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA

..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).

http://www.stemcellsgroup.com/advisory-board/

Fortright Professional Advisors!



LAHO$

LAHO! possibilities for massive gains.

GSCG Partner Magellan..

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149372964

CSL snags a preclinical stem cell therapy in $416M..
https://endpts.com/csl-snags-a-preclinical-stem-cell-therapy-in-416m-calimmune-buyout/

..Therapeutics Rallies as Gene Stocks Get Hot Again
2/27/2019 9:58am EDT

..Spark Bought Out

Roche offered to buy Spark for $114.50 per share in cash for a total price tag of $4.8 billion.

https://investorplace.com/2019/02/crispr-therapeutics-rallies-as-gene-stocks-get-hot-again/amp/

A one percent equivalent for possible buyout equals $1 per share!

Probabilities..


LAHO$

LAHO! possibilities for massive gains.

GSCG Partner Magellan..

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149372964

..Therapeutics Rallies as Gene Stocks Get Hot Again
2/27/2019 9:58am EDT

..Spark Bought Out

Roche offered to buy Spark for $114.50 per share in cash for a total price tag of $4.8 billion.

https://investorplace.com/2019/02/crispr-therapeutics-rallies-as-gene-stocks-get-hot-again/amp/

At 1% aforementioned, buyout equals $1 per share!


LAHO$

LAHO! Epic summer run, have a good weekend.



LAHO$

LAHO..cell therapy market [will] grow..around 36% by 2021,” read the report.

“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive

Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31 Million
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30

https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/

LAHO: Global Stem Cells Group Announces Opening of Two New Stem Cell Centers

..This brings the total number of global Stem Cell centers to 36 worldwide in 27 countries.
..The new clinic in Valencia will be the group's third operation in Spain and the fourth in Europe.

https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503

Much potential given the global presence and Network.


LAHO$

LAHO! Cellgenic..regenerative medicine and cellular therapies since 2005..


UNITED STATES STEM CELL THERAPY
More than a Decade of Stem Cell Therapy Experience

Safety along with the highest standards of medical ethics define the Cellgenics system.
We do not take stem cell treatments lightly. Our medical team adheres strictly to our inclusion and exclusion criteria. This leads to a higher efficacy rate because we are aware that not all conditions can be treated successfully with fresh autologous stem cells.

Our therapeutic protocols are designed and tailored for each patient, this means we have different systems in place for the isolation and delivery of the stem cells.
The Cellgenic sytem differs from other stem cell therapy facilities because:

Proprietary protocols have been developed by our faculty and implemented by hundreds of physicians around the world
There is a high rate of therapy success
An ethics committee has approved ongoing clinical trials

..Patients Treatment
+2000

Improvement and satisfaction
95%

Medical cases done
5000

http://cellgenic.com/our-story/#
http://cellgenic.com/articles/

..The Global Stem Cell Group’s Stem Cell Center is a unique international network of medical practices, dedicated to bringing the latest advancements in regenerative medicine to patients around the world

..SSCA President Daeyong Kim, Ph.D. Names Junaid Sayed, M.D. President of ISSCA’s U.S. Chapter

http://stemcellcenter.net/issca-president-daeyong-kim-ph-d-names-junaid-sayed-m-d-president-isscas-u-s-chapter/

LAHO$

LAHO..Finra most active OOTC Equity!

http://finra-markets.morningstar.com/MarketData/EquityOptions/default.jsp

Buy Vol. 167.317.834 Sell Vol. 146,298.565
https://ih.advfn.com/stock-market/USOTC/lans-holdings-inc-LAHO/trades

LAHO$

LAHO! Physician Network of Regenerative Medicine Practitioners..AdiStem N-Biotel

Burton Feinerman, M.D FL

Abu Dhabi, UAE

Syed M.D. Orland FL


http://stemcellcenter.net/


Rare Gem, VALUE!

LAHO$

LAHO! Partner..GSCG Adimarket to Represent Magellan..

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149372697

Acquirer: Lans Holdings Inc. (LAHO)
Acquiree: Global Stem Cells Group Inc.
Details: Lans Holdings Inc. (OTCPink: LAHO) is pleased to announce that it has entered into a binding letter of intent to acquire 100% of Global Stem Cells Group Inc. (GSCG).

https://www.investhelp.com/slideshows/?slideshow=mergers&page=90

Adimarket announces launch of Cellgenic stem cell protein extract hair restoration product


..GSCG affiliate Adimarket announces the launch of the Cellgenic adipose-derived stem cell hair restoration application that maximizes the skin and hair follicles’ own revitalizing capabilitie

..When used by aesthetic practitioners, CADPE provides safe, cutting-edge hair thickening and hair follicle proliferation results that are CTFA-approved, take less application time than other hair restoration processes, and is backed by medical research.

http://www.stemcellsgroup.com/cadpe-stem-cell-hair-restoration-application/

..Our work is a comprehensive turn key solution for the set-up and operation of a laboratory for the culture of human pluripotent Stem Cells . The process of establishing a STEM CELL PROCESSING CENTER can be divided into two equally important parts. One is completely administrative and includes developing protocols, seeking approval, and establishing reporting processes and documentation. The other part of establishing a STEM CELL laboratory involves the physical plant and includes design, equipment and personnel

http://stemcellslab.net/about/
http://stemcellcenter.net/members/
www.stemcelltraning.net


Many lines of revenue & much more!


LAHO$

LAHO! GSCG Partner Magellan, $65 per share, buyout possible?


https://www.nasdaq.com/symbol/mgln


Yes they are my friend, several times-x-Devices.

Platelet and growth factor concentrations in activated platelet-rich plasma: a comparison of seven commercial separation systems.

..Platelet-rich plasma (PRP) is blood plasma that has been enriched with platelets. It holds promise for clinical use in areas such as wound healing and regenerative medicine, including bone regeneration...

https://www.ncbi.nlm.nih.gov/pubmed/24748436

Autologous Platelet Gel Applications During Cardiovascular Surgery: Effect on Wound Healing

CONCLUSIONS

In this pilot study, we found support that chest and leg pain were decreased in the experimental group, and we observed that the experimental group had less bruising
..
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682529/
https://www.istobiologics.com/resources/magellan-ifu

..This letter will allow you to begin marketing your device as described in your 51O(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

https://www.accessdata.fda.gov/cdrh_docs/pdf2/k021902.pdf
https://www.prnewswire.com/news-releases/arteriocyte-medical-systems-announces-another-fda-approval-for-its-magellan-technology-156970385.html
https://hitconsultant.net/2018/01/17/magellan-health-launches-first-fda-approved-prescription-digital-therapeutic/
https://www.dicardiology.com/product/fda-clears-hansen-medical%E2%80%99s-magellan-10-french-robotic-catheter
https://www1.magellanrx.com/documents/2019/03/mrx-report_2018-summer.pdf/

Seen-missed several buyouts not missing another.

Glta

LAHO! GSCG Adimarket to Represent Magellan..


http://www.stemcellsgroup.com/magellan-autologous-platelet-separator/screen-shot-2017-11-28-at-2-42-03-am/
Global Stem Cells Group and its subsidiary Adimarket named representatives for Magellan Autologous Platelet Separator in Latin America and Middle East.

Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, and its subsidiary Adimarket have been named to represent the Magellan Autologous Platelet Separator in Latin America and Middle East.

Developed by Arteriorcyte Medical Systems, a leading medical device company headquartered in Hopkinton, Mass., the Magellan Autologous Platelet Separator is a high-tech, automated dual spin processing system designed for use in clinical laboratories or intraoperatively at the point-of-care for safe and rapid preparation of high-quality, platelet-rich plasma (PRP) as well as platelet poor plasma (PPP).

Global Stem Cells Group CEO Benito Novas says the Magellan system is a perfect fit for GSCG and Adimarket’s ever-growing list of high-tech regenerative medicine products and equipment, made available to physicians and qualified practitioners through the Adimarket online store.

“We share Arteriocyte’s commitment to research and development of blood component technology to advance treatments that benefit patients in the field of regenerative medicine,” Novas says. “The Magellan system furthers GSCG’s drive to invest in platelet separation technologies that focus on the development of new surgical applications for PRP and elevates these technologies to the next level.”

The fully-automated Magellan system is specifically designed to fractionate blood at bedside without a need for manual manipulation. At the end of its cycle, the Magellan PRP is delivered into a collection syringe, ready for immediate application.

As an industry leader, Adimarket added the Magellan Autologous Platelet Separator System to its online regenerative medicine store to allow physicians to meet the specific needs of each patient with fully customizable product volumes and platelet concentrations. The system can be programmed to deliver a volume of 3 – 10 mL from each processing cycle, allowing practitioners to customize the concentration per mL within the PRP. The Magellan system is approved for three processing cycles per disposable separation chamber, allowing for a maximum of 30 mL of product.

For more information, visit the Adimarket regenerative medicine online store website, email info@stemcellsgroup.com, or call 305-560-5337.

About Global Stem Cells Group
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/

http://www.stemcellsgroup.com/magellan-autologous-platelet-separator/magellan_logo2/

https://www.stemcellsgroup.com/category/press-releases/page/7/

Stakeholders from past to present in the work's!


LAHO$

LAHO!..Global Stem Cell centers to 36 worldwide in 27 countries.

Lans Holdings, Inc.

Our Email is:-investors@lansholdings.com
investors@lans.holdings
info@lansholdings.com
bizdev@lansholdings.com

For further information, please contact:
Telephone: +1.786.786.5758 and 305-755-7451

https://www.otcmarkets.com/stock/LAHO/disclosure

..(GSCG)..binding letter..to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/



.. market value of US $297 billion by 2022

https://www.marketwatch.com/press-release/stem-cells-market-size-is-projected-to-be-around-us-297-billion-by-2022-2018-06-19


LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain
..
“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”

https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239

Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.

http://scontent-iad3-1.xx.fbcdn.net/v/t1.0-9/20258013_1469196269824014_3869263465234727164_n.jpg?_nc_cat=107&_nc_ht=scontent-iad3-1.xx&oh=4fe0dee343e549f647daa248594d8df5&oe=5D8F89DA">http://scontent-iad3-1.xx.fbcdn.net/v/t1.0-9/20258013_1469196269824014_3869263465234727164_n.jpg?_nc_cat=107&_nc_ht=scontent-iad3-1.xx&oh=4fe0dee343e549f647daa248594d8df5&oe=5D8F89DA" />[/img]
....“Our objective is to bring this cutting-edge 3D bioprinting technology to scientists and regenerative medicine researcher throughout Lain America,”






https://www.facebook.com/pg/globalstemcells/photos/?ref=page_internal

ISSCA Launches New Stem Cells Certification Course.

•Santiago de Chile, Chile: September 5, 2019
• Bogota, Colombia: October 4, 2019
• Buenos Aires, Argentina: October 11, 2019
• Miami, Florida (in English): November 1, 2019

https://www.prunderground.com/wp-content/uploads/2017/07/GSCG-logo.jpg

LAHO CEO Dave Christensen at Nasdaq highly skilled.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841


..ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
https://www.stemcellsgroup.com/

Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/

Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas

..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .

https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-


GLTA

LAHO$

LAHO! FDA (fooling daily artist)

..To do your part to stay safe, make sure that any stem cell treatment you are considering is either:

FDA-approved, or;

https://www.fda.gov/consumers/consumer-updates/fda-warns-about-stem-cell-therapies#Advice



https://stemcells.nih.gov/trials.htm

FDA wants approval (money) so folks perceive safety?

LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain

by Benito Novas / Tuesday, 11 June 2019 / Published in Press Releases

The new center will continue the Global Stem Cells Group’s mission to expand access to stem cell therapies and training to physicians across the globe.

MIAMI LAKES, Florida—A new Stem Cell Center is set to open its doors in Spain. Benito Novas, CEO of the Global Stem Cells Group (GSCG), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, has announced the opening of the group’s Valencia, Spain center. The new clinic will be the group’s third operation in Spain and the fourth in Europe.

The Global Stem Cells Group’s Valencia center joins the already existing centers in , which include locations in Bruselas, Madrid, and Barcelona. With the opening of the new center, the GSCG will boast 41 such locations across the globe.

Novas noted that the group has been focusing its efforts on opening its cutting-edge Stem Cell Centers in Europe, in part due to the group’s recognition that regenerative medicine is a fast-growing field across the continent.

“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”

In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.

“I am thrilled to lead the efforts at the Stem Cell Center in Valencia,” said Dra. Caicedo. “I am looking forward to utilizing cutting-edge therapy options based in stem cell science to help treat patients suffering from hair loss. Additionally, the opportunity is an exciting one given the Global Stem Cells Group’s excellent reputation and stature as the longest-standing and most respected stem cells network. I’m looking forward to learning from other physicians in the network across the globe and sharing my expertise with other practitioners in regenerative medicine.”

The GSCG will provide the Valencia center with the newest and most effective marketing tools in the field to help the franchise increase its performance in recruiting new patients.

Marketing support is one of the many benefits of joining the GSCG’s expanding global network of clinics. Being part of the group’s network gives physicians access to other experts within the its global network, add to their practice the newest regenerative medicine protocols, and have access to a proven marketing strategy developed by GSCG.

http://www.stemcellsgroup.com/.
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239




https://medec.es/conoce-medec/#equipoMedico


LAHO$

ISSCA Launches New Stem Cells Certification Course.

Industry: Healthcare

The newly developed program gives physicians the opportunity to learn the latest methods and knowledge in the field of regenerative medicine.

Miami Lakes, FL (PRUnderground) June 11th, 2019

Tweet
Delicious

The International Society for Stem Cells Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, has announced a new course for physicians interested in gaining certification in regenerative medicine. The course was developed out of the group’s highly successful global conference certifications, providing physicians a newly designed and more intimate and personalized smaller group training through which to gain critical skills and knowledge in the field of regenerative medicine.

Through completion of the certification course, physicians will learn how they can add cell-based product protocols to their existing medical practices, including those using exosomes, amniotic fluid, and cord blood.

A host of global experts practicing within the field will be on hand to lead attendees through the new training. They will share first-hand scientific information on the science behind cell therapies and cell-based products and their clinical applications. In-depth examination of clinical trials that demonstrate the safety and efficacy of cell-based products will also be part of the one-day training.

Physicians attending the certification will also learn how to distinguish between the most popular cellular products on the market and what factors to keep in mind when choosing stem cell protocols as a therapeutic alternative. Course faculty will additionally lead attendees through how to structure treatment plans and protocols for patients who may benefit from stem cell therapies.

“We are pleased to be able to offer this exciting and informative new training to physicians interested in adding stem cell treatment options to their current medical practices,” said Benito Novas, CEO of ISSCA. “We seek to remain at the forefront of the stem cells field by continuously innovating and offering the global community the training they need to deliver effective, cutting edge treatment options to their patients. We decided to offer this new training in part due to the demand for it from our customers, who are eager to expand their knowledge base and offer new treatment options to their patients.”

ISSCA has set four dates and locations for its new certification course, and this is the first time such certification has been held by the group outside of the United States:

•Santiago de Chile, Chile: September 5, 2019

• Bogota, Colombia: October 4, 2019

• Buenos Aires, Argentina: October 11, 2019

• Miami, Florida (in English): November 1, 2019

To learn more about ISSCA’s latest certification program and to register, or to learn more about ISSCA, visit https://www.issca.us/.

About Global Stem Cells Group

Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.

https://www.prunderground.com/issca-launches-new-stem-cells-certification-course/00157482/

LAHO$

LAHO CEO Dave Christensen at Nasdaq highly skilled.

.."This technology is the Future. The pioneers and innovators, who embrace it and deploy it, will clearly have the sustainable competitive advantage."? - David Christensen, CEO
https://www.linkedin.com/company/tnt-blockchain


Lans Holding Inc
..A Security Technology Company, Focused on Delivering Global Commerce Solutions, Encrypted Communications and Managed Services
..Specialties

Payment Engine - EMV Cross Border Enabled Gateway, IoD - Infrastructure On Demand, Paysperity Point Of Sale - POS Solutions, Fractional IT Services - Outsourced Managed Services

https://www.linkedin.com/company/lans-holdings-inc?trk=similar-companies_org_title


Global Stem Cells Group

About us

Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine become a reality for patients around the world. We’ve brought together six operating companies, each focused on the cutting edge of healing with stem cell treatments into one global network. Each of the companies has a different mission and each company has based its mission on authentic and proven research and science
Website

http://www.stemcellsgroup.com
https://www.linkedin.com/company/global-stem-cells-group?trk=similar-companies_org_title

Ceo highly skilled!

LAHO$

LAHO! Company Directors, team.

Trevor Allen
David Christensen
Anthony Ribas

https://www.otcmarkets.com/stock/LAHO/profile

David Christensen..Mr. Christensen has over 25 years’ experience in strategy deployment..

https://www.otcmarkets.com/filing/html?id=13457482&guid=hs6yUWhpoJxwp3h
http://www.tntblockchains.com/in.html

Anthony Ribas..

Lans Holdings, Inc DBA PaySperity offers the following products or services: Internet - eCommerce, Payment Processing and Point of Sale (POS) Solutions.

https://myopportunity.com/profile/anthony-ribas/sl
..Trevor leads Qualfon’s Business Development, Mergers and Acquisitions, and Enterprise Solutions teams.

https://www.qualfon.com/who-we-are/executive-leadership/

Benito Novas
Chief Executive Officer
Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/

Global Stem Cells Group

Brings leadership in stem cell research, patient applications, and training to you through our state-of-the-art global network of companies. Our mission is to enable physicians to make the benefits of stem cell medicine a reality for patients around the world.

http://www.stemcellsgroup.com/

..We've brought together eight companies on the cutting edge of #healing into one global network. #stemcell

14750 NW 77th Court, MiamiLake
stemcellsgroup.com
https://twitter.com/StemCellGroupUS
GLTA


LAHO$

LAHO Sec reportd LOI, $Big money to be made!!

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149267993
https://www.otcmarkets.com/stock/LAHO/disclosure

Factfinders suggest none-compliance mucho penalty+attorney fees!
Stem cells Global Inc..is Global!

LAHO$

LAHO Beautiful team, technology and wellness!

..Global Stem Cells Group Inc. (GSCG) is pleased to announce that it has entered into a binding letter of intent to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)

https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/

https://www.otcmarkets.com/stock/LAHO/disclosure

Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas

..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .

https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149267993

LAHO$

LAHO!.. Mr. Christensen has over 25 years’ experience in strategy deployment including unique expertise in global supply chains, Point Of Sale, logistics, freight, distributions, inventories, service repairs, CRM, customer service and call center work. Additionally, his International team includes industry experts in engineering, IT hardware, ERP applications, security management, as well as marketing and PR. As a Black Belt, he uses the best tools from Lean/Six Sigma Principles of Strategy Deployment. Dave is a known expert for not only developing Strategic Business Objectives, but also for his methodology of Execution Excellence.

https://www.otcmarkets.com/filing/html?id=13457482&guid=hs6yUWhpoJxwp3h

Dave Christensen

http://www.tntblockchains.com/in.html

Laho$ Ceo well versed!

LAHO! CapitalCube Stats.. Bullish.. Undervalued..

https://online.capitalcube.com/#!/stock/US/US%20OTC/LAHO/summary

LAHO$

Looking good, green week ahead!

..Counts: 3 bullish, 0 bearish

https://otcbb.swingtradebot.com/equities/LAHO:OTC

LAHO$

LAHO! Rsi Over Sold Burried!

http://www.stockta.com/cgi-bin/analysis.pl?symb=LAHO&mode=table&table=rsi

Load up time.


LAHO$

LAHO! The Fascinating Rise of Lans Holdings Inc (OTCMKTS: LAHO

Lans Holdings Inc (OTCMKTS: LAHO) has been on an explosive rise over the past few weeks after the Company announced a binding LOI to acquire 100% of Global Stem Cells Group Inc. (GSCG) an emerging operator in the booming global stem cell market.

LAHO has transformed into a volume leader in recent weeks seeing an explosive rise from a start point in the low triple z’s and recent highs of $0.0017. With a significant dip taking place traders are loading up for another run.

https://www.microcapdaily.com/the-fascinating-rise-of-lans-holdings-inc-otcmkts-laho/124619/

LAHO$

Lans Holdings Inc. — Global Stem Cells Group Inc.

Acquirer: Lans Holdings Inc. (LAHO)
Acquiree: Global Stem Cells Group Inc.
Details: Lans Holdings Inc. (OTCPink: LAHO) is pleased to announce that it has entered into a binding letter of intent to acquire 100% of Global Stem Cells Group Inc. (GSCG).

https://m.theonlineinvestor.com/slideshows/?slideshow=mergers&page=66
https://www.otcmarkets.com/stock/LAHO/disclosure

Blue Horseshoe Stocks: LAHO

When we brought LAHO to our readers exactly a week ago today, it was trading at .0005. After just a couple of sessions, it had registered a huge 240% move to a high of .0017. The stock then pulled back .0006 on Friday, and over another two sessions, ran back to .0014. That marks another upswing of 133% bring our four-day cumulative total to 373%

As sub-penny plays tend to do, we would expect to see LAHO continue to bounce around in this fashion. Savvy traders may yet see similar chances to profit, moving forward.

http://bullinadvantage.com/blue-horseshoe-stocks-laho-update-more

..2019.Added Note: The majority of the companies that we cover in our press releases, the Daily Report Newsletter, and on this website are not paid clients.

Laho$

Laho profits!

April 2018

Accredited Investor. TDUSA is an Accredited Investor, as such term is defined in Regulation D promulgated under the Securities Act.

https://www.sec.gov/Archives/edgar/data/1422059/000166357718000217/ex10_5.htm

2x Accredited Investor for Laho!

Laho big loading,

Laho GSCG companies owned!

Companies
ADIMarket

http://www.stemcellsgroup.com/
https://www.adimarket.net/
http://stemcellslab.net/
http://stemcellcenter.net/
http://stemdata.org/
https://www.stemcelltraining.net/
https://twitter.com/StemCellGroupUS

Laho green week!

LAHO! ADIMarket GSCG

Contact Us

14750 NW 77th Ct #304, Miami Lakes, FL 33016
Email: info@stemcellsgroup.com
Phone: +1 305 560 5337

https://www.adimarket.net/

LAHO$

LAHO! Global Stem Cells Group Inc

Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.

https://www.ktvn.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine

Global Stem Cells Group to Host Stem Cells and Regenerative Medicine Conference in Miami

https://www.issca.us/

Laho technology will certainly bring more giants profit$$.

Harvard

Breakthrough research shows that stem cell genes can be edited in living systems

..the findings have major implications for biotechnology research and the development of therapeutics for genetic diseases

https://news.harvard.edu/gazette/story/2019/06/breakthrough-harvard-research-shows-stem-cell-genes-can-be-edited-in-living-systems/

..Stem Cell Treatments Flourish With Little Evidence That They Work

..The Global Stem Cell manufacturing Market is expected to reach USD 16.51 Billion by 2025, from USD 10.28 Billion

Major Market competitors/players: Global Stem Cell manufacturing Market

Some of the major players operating in the stem cell manufacturing market are Thermo Fisher Scientific. Merck Group, Becton, Dickinson and Company. Holostem Advanced Therapies, JCR Pharmaceuticals, Organogenesis Inc, Osiris Therapeutics, Osiris Therapeutics, Vericel Corporation, AbbVie, American CryoStem, AM-Pharma, Anterogen.Co.,Ltd, Astellas Pharma, Bristol-Myers Squibb, Apceth Biopharma, Cellular Dynamics International, Rheacell, Takeda Pharmaceutical, Teva Pharmaceutical Industries Ltd. ViaCyte, VistaGen Therapeutics Inc, Translational Biosciences, GlaxoSmithKline plc, Daiichi Sankyo Company, Limited, among others.

The F.D.A. has taken an industry-friendly approach toward companies using unproven cell cocktails to treat people desperate for relief from aging or damaged joints.

https://www.nytimes.com/2019/05/13/health/stem-cells-fda.html

FDA wants partners with money, efficacy of treatment is proven.